Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 14356-40-2
2. Sodium;4-tridecylbenzenesulfonate
3. Sodium N-tridecylbenzenesulfonate
4. 4-tridecylbenzenesulfonic Acid Sodium Salt
5. Cv34z63u2i
6. Benzenesulfonic Acid, 4-tridecyl-, Sodium Salt
7. Sodium Tridecylbenzenesulphonate
8. Conoco C 650
9. Sodium Tridecylbenzene Sulfonate
10. Unii-cv34z63u2i
11. Hsdb 775
12. Einecs 247-536-3
13. Tridecylbenzene Sulfonic Acid Sodium Salt
14. Tridecylbenzenesulfonic Acid, Sodium Salt
15. Unii-dtk0t310j6
16. Dtk0t310j6
17. Schembl3853262
18. Benzenesulfonic Acid, Tridecyl-, Sodium Salt (1:1)
19. Benzenesulfonic Acid, P-tridecyl-, Sodium Salt
20. Q27275831
21. Benzenesulfonic Acid, 4-tridecyl-, Sodium Salt (1:1)
| Molecular Weight | 362.5 g/mol |
|---|---|
| Molecular Formula | C19H31NaO3S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 13 |
| Exact Mass | 362.18916030 g/mol |
| Monoisotopic Mass | 362.18916030 g/mol |
| Topological Polar Surface Area | 65.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 371 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
3. 3= MODERATELY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) 0.5-5 G/KG; BETWEEN 1 OUNCE & 1 PINT (OR 1 LB) FOR 70 KG PERSON (150 LB). /ALKYL ARYL SODIUM SULFONATES/
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-177
UPTAKE OF LINEAR ALKYLBENZENESULFONATE (LAS) IN DAPHNIA PROMELAS & FATHEAD MINNOWS WAS FUNCTION OF CHAIN LENGTH & EXPOSURE CONCN. IN WHOLE ORGANISM, DRY WT BIOCONCN FACTORS (BCF) WERE 500-4000 FOR DAPHNIDS & 200-2000 FOR FATHEAD MINNOWS.
COMOTTO RM ET AL; ASTM SPEC TECH PUBL (ISS STP 667) AQUAT TOXICOL: 232 (1979)
IN FATHEAD MINNOW TISSUES, GREATEST AMT OF (14)C FROM (14)C-LAS WAS DETECTED IN GALL BLADDER (BIOCONCN FACTORS (BCF) RANGING FROM 20000-70000) WHILE LEAST AMT OF (14)C WAS DETECTED IN MUSCLE (BCF REMAINING IN RANGE OF 100-400).
COMOTTO RM ET AL; ASTM SPEC TECH PUBL (ISS STP 667) AQUAT TOXICOL: 232 (1979)
IN DEPURATION STUDIES, MORE THAN 85% OF LINEAR ALKYLBENZENESULFONATE (LAS) WAS CLEARED FROM ALL TISSUES WITHIN 3-4 DAYS, APPROX 100% WITHIN 10 DAYS. RESULTS SUGGESTED THAT FATHEAD MINNOWS METABOLIZED LAS BUT DAPHNIDS DID NOT.
COMOTTO RM ET AL; ASTM SPEC TECH PUBL (ISS STP 667) AQUAT TOXICOL: 232 (1979)
SUBSTANTIAL PROPORTIONS OF (14)C CONTENT IN TISSUES OF FATHEADS EXPOSED TO (14)C-LAS WERE NOT PRESENT AS LINEAR BENZENESULFONATE (LAS), BUT PRESUMABLY AS METABOLITES (30-50%) IN MUSCLE TISSUES & APPROX 97% IN GALL BLADDER.
COMOTTO RM ET AL; ASTM SPEC TECH PUBL (ISS STP 667) AQUAT TOXICOL: 232 (1979)
ABOUT THIS PAGE
39
PharmaCompass offers a list of Conoco C 650 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Conoco C 650 manufacturer or Conoco C 650 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Conoco C 650 manufacturer or Conoco C 650 supplier.
PharmaCompass also assists you with knowing the Conoco C 650 API Price utilized in the formulation of products. Conoco C 650 API Price is not always fixed or binding as the Conoco C 650 Price is obtained through a variety of data sources. The Conoco C 650 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Conoco C 650 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Conoco C 650, including repackagers and relabelers. The FDA regulates Conoco C 650 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Conoco C 650 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Conoco C 650 supplier is an individual or a company that provides Conoco C 650 active pharmaceutical ingredient (API) or Conoco C 650 finished formulations upon request. The Conoco C 650 suppliers may include Conoco C 650 API manufacturers, exporters, distributors and traders.
Conoco C 650 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Conoco C 650 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Conoco C 650 GMP manufacturer or Conoco C 650 GMP API supplier for your needs.
A Conoco C 650 CoA (Certificate of Analysis) is a formal document that attests to Conoco C 650's compliance with Conoco C 650 specifications and serves as a tool for batch-level quality control.
Conoco C 650 CoA mostly includes findings from lab analyses of a specific batch. For each Conoco C 650 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Conoco C 650 may be tested according to a variety of international standards, such as European Pharmacopoeia (Conoco C 650 EP), Conoco C 650 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Conoco C 650 USP).
